PATENT CLAIM ANALYSIS

Application Number: 15876478
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["435", "114000"]

Abstract:
Disclosed is a method for producing L-citrulline using recombinant  Corynebacterium crenatum  cells as whole-cell biocatalysts. The present invention provides a recombinant  C. crenatum  that expresses an exogenous arginine deiminase gene from  Lactobacillus brevis . The recombinant  C. crenatum  SDNN403 is used as biocatalysts for converting L-arginine to produce L-citrulline. Using the method of the invention, the concentration of L-citrulline reached 301.4 g/L after a 48 hr conversion reaction, and the molar conversion rate reached 99.9%.

Claim (Index 2):
The method of  claim 1 , wherein said arginine deiminase gene is from  Lactobacillus brevis , having a sequence of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 86.0
- Lexical Diversity: 1.47273
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15736544', '13214398', '11912236', '10674666', '13878745']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.559171193597131
- 35 USC 102 Novelty (BERT): 0.4822776796873687
- Combined Prediction Score: 0.5514818422061547
- Mean Citation Score: 189.376272
- Max Citation Score: 198.3673
- Similarity Product: 156.33695892946722

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test